In this episode of SurgOnc Today®, Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, is joined by Dr. James R. Howe from the University of Iowa and Dr. Nadine Mallak from the Oregon Health and Science University. They discuss how somatostatin receptor PET imaging, such as DOTATE-PET, can be used to guide and support the surgical management of pancreatic neuroendocrine tumors.

Moderator:

Julie Hallet MD, Msc;

Associate Professor of Surgery. University of Toronto, Toronto, Canada;

Surgical Oncologist, Susan Leslie Clinic for Neuroendocrine Tumors – Sunnybrook Health Sciences Centre, Toronto, Canada

Vice-Chair, HPB DSWG, SSO

Faculty:

James R. Howe, MD

Professor of Surgery and Director of Surgical Oncology and Endocrine Surgery, Roy J. and Lucille A. Carver University of Iowa College of Medicine, Iowa City, Iowa

Nadine Mallak, MD

Associate Professor, Department of Diagnostic Radiology, Nuclear Medicine and Body Imaging sections

Director, PET/MRI, Clinical, Oregon Health and Science University, Portland, OR

References

NANETS guidelines for the surgical management of pancreatic neuroendocrine tumors

SNMMI appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors